Next Article in Journal
Plasma Free Fatty Acids Metabolic Profile with LC-MS and Appetite-Related Hormones in South Asian and White European Men in Relation to Adiposity, Physical Activity and Cardiorespiratory Fitness: A Cross-Sectional Study
Previous Article in Journal
Role of Intestinal Microbiota in Metabolism of Gastrodin In Vitro and In Vivo
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

Retraction: Carulli, L. et al. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019, 9(2), 25

by
Lucia Carulli
1,
Giulia Zanca
1,
Filippo Schepis
1,
Erica Villa
1,* and
Metabolites Editorial Office
2
1
Division of Gastroenterology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria and University of Modena and University of Modena and Reggio Emilia, 41124 Modena, Italy
2
St. Alban-Anlage 66, 4052 Basel, Switzerland
*
Author to whom correspondence should be addressed.
Metabolites 2019, 9(4), 70; https://doi.org/10.3390/metabo9040070
Submission received: 9 April 2019 / Accepted: 9 April 2019 / Published: 11 April 2019
As the authors of the title paper [1], it is with great regret that we inform the readership of Metabolites that we have asked the journal’s publisher, MDPI, to retract the paper from the scientific literature. Due to human error, we included contents similar to article [2], which has already been published by Pirola et al. We apologize to the readership of Metabolites and to the authors of [2] for any inconvenience caused.
MDPI is a member of the Committee on Publication Ethics (COPE) and takes the responsibility to enforce strict ethical policies and standards very seriously. To ensure the integrity of the publication record, [1] is retracted and shall be marked accordingly.

References

  1. Carulli, L.; Zanca, G.; Schepis, F.; Villa, E. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019, 9, 25. [Google Scholar] [CrossRef] [PubMed]
  2. Pirola, C.J.; Sookoian, S. Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity. World J. Gastroenterol. 2018, 24, 1601–1615. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Carulli, L.; Zanca, G.; Schepis, F.; Villa, E.; Metabolites Editorial Office. Retraction: Carulli, L. et al. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019, 9(2), 25. Metabolites 2019, 9, 70. https://doi.org/10.3390/metabo9040070

AMA Style

Carulli L, Zanca G, Schepis F, Villa E, Metabolites Editorial Office. Retraction: Carulli, L. et al. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019, 9(2), 25. Metabolites. 2019; 9(4):70. https://doi.org/10.3390/metabo9040070

Chicago/Turabian Style

Carulli, Lucia, Giulia Zanca, Filippo Schepis, Erica Villa, and Metabolites Editorial Office. 2019. "Retraction: Carulli, L. et al. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019, 9(2), 25" Metabolites 9, no. 4: 70. https://doi.org/10.3390/metabo9040070

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop